EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieVergleichsstudie

Validation of the V‐RESOLVE Score for Side Branch Occlusion in the PROGRESS‐BIFURCATION Registry

Dimitrios Strepkos iD, Michaella Alexandrou iD, Deniz Mutlu iD, Pedro E P Carvalho iD, Ozgur S Ser iD, Oleg Krestyaninov iD, Dimitri Khelimskii iD, Barkin Kultursay iD, Ali Karagoz, Ufuk Yildirim, Korhan Soylu, Mahmut Uluganyan und 7 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70023 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Dimitrios Strepkos und 18 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Coronary Occlusion, Percutaneous Coronary Intervention, Coronary Artery Disease, Coronary Angiography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We validated the Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion (V‐RESOLVE) score for predicting side branch occlusion (SBO) in an independent registry.

Aims

We sought to evaluate the predictive performance of the V‐RESOLVE score.

Methods

We compared the characteristics, V‐RESOLVE scores, and outcomes of 791 patients (937 bifurcation PCIs) who underwent provisional bifurcation PCI performed at five centers between 2014 and 2024 from the PROGRESS‐BIFURCATION registry.

Results

The incidence of SBO was 13% ( n = 124). SBO patients had lower rates of hypertension, diabetes, prior coronary artery bypass graft surgery (CABG), and prior PCI but higher angiographic complexity, with higher left anterior descending artery stenoses, lower side branch diameter, higher side branch diameter stenoses, and lower rates of ostial lesions. SBO patients had higher median V‐RESOLVE scores (16 vs. 12, p < 0.001) and were more likely to convert from provisional to two‐stent strategies (21.0% vs. 5.8%, p < 0.001) and to require plaque modification (37.9% vs. 18.9%, p < 0.001). SBO patients had lower technical (76.6% vs. 95.9%, p < 0.001) and procedural (72.8% vs. 92.6%, p < 0.001) success and similar in‐hospital major adverse cardiovascular events (MACE) (6.1% vs. 3.8%, p = 0.306). The quartile cutoffs for V‐RESOLVE scores were 9 for the first quartile of patients, 12 for the second, and 18 for the third with a maximum of 43. SBO rates were 7.5%, 9.8%, 17.5%, and 15.3% for each quartile ( p < 0.001). Using the cutoff values used to develop the score (0−3, 4−7, 8−11, 12−43), the SBO rates were 7.0%, 7.0%, 8.6%, 15.7%, respectively ( p < 0.001). The area under the curve (AUC) of the V‐RESOLVE score for predicting SBO was 0.61 (95% confidence intervals 0.56−0.66).

Conclusions

The predictive value of the V‐RESOLVE score for SBO in the PROGRESS‐BIFURCATION registry was modest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary OcclusionPercutaneous Coronary InterventionCoronary Artery DiseaseCoronary AngiographyDecision Support TechniquesHumansRegistriesMaleFemaleAgedPredictive Value of TestsMiddle AgedRisk AssessmentTreatment OutcomeRisk FactorsReproducibility of ResultsTime FactorsUnited StatesIncidence

Stichwörter der Autor:innen

V‐RESOLVEbifurcation lesionpercutaneous coronary interventionside branch occlusion

Autor:innen und Institutionen

  • Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.
  • Kartal Kosuyolu Postgraduate Training and Research Hospital, Istanbul, Turkey.
  • Ondokuz Mayis University Medical Faculty, Samsun, Turkey.
  • Bezmialem Vakif University, Istanbul, Turkey.

ORCID-Profile: Dimitrios Strepkos, Michaella Alexandrou, Deniz Mutlu, Pedro E P Carvalho, Ozgur S Ser, Oleg Krestyaninov, Dimitri Khelimskii, Barkin Kultursay, Olga Mastrodemos, Sandeep Jalli, Emmanouil S Brilakis

Zitieren

APA

Strepkos, D., Alexandrou, M., Mutlu, D., Carvalho, P. E. P., Ser, O. S., Krestyaninov, O., Khelimskii, D., Kultursay, B., Karagoz, A., Yildirim, U., Soylu, K., Uluganyan, M., Mastrodemos, O., Rangan, B. V., Jalli, S., Voudris, K., Nicholas Burke, M., Sandoval, Y., & Brilakis, E. S. (2025). Validation of the V‐RESOLVE Score for Side Branch Occlusion in the PROGRESS‐BIFURCATION Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70023

Vancouver

Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Ser OS, Krestyaninov O, et al. Validation of the V‐RESOLVE Score for Side Branch Occlusion in the PROGRESS‐BIFURCATION Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70023

BibTeX
@article{Strepkos2025,
  author = {Strepkos, Dimitrios and Alexandrou, Michaella and Mutlu, Deniz and Carvalho, Pedro E P and Ser, Ozgur S and Krestyaninov, Oleg and Khelimskii, Dimitri and Kultursay, Barkin and Karagoz, Ali and Yildirim, Ufuk and Soylu, Korhan and Uluganyan, Mahmut and Mastrodemos, Olga and Rangan, Bavana V and Jalli, Sandeep and Voudris, Konstantinos and Nicholas Burke, M and Sandoval, Yader and Brilakis, Emmanouil S},
  title = {Validation of the V‐RESOLVE Score for Side Branch Occlusion in the PROGRESS‐BIFURCATION Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70023}
}
Kostenlos starten →